<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="icon" href="theme/dist/images/favicon.icon">

    <title>GenomePaint</title>
</head>
<style>
    body {
        font-family: Verdana, Geneva, Tahoma, sans-serif;
        font-size: 1.15em;
        line-height: 1.5em;
        margin: 3vw;

    }

    .section-header {
        font-family:'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
        text-align: center;
    }

    a {
        color: #1774dc;
    }

    .list-group {
        list-style: none;
        max-width: 90vw;
        margin: auto;
    }

    .list-group-item {
        padding: 10px;
        border: 1px solid rgba(0,0,0,.125);
    }

    .list-group-item > a {
        text-decoration: none;
    }

    .list-group-item > a:hover {
        text-decoration: underline;
    }

</style>
<body>
    <noscript>This page requires JavaScript. Please enable it in your browser settings.</noscript>
	<!--
    <h2 class="section-header">GenomePaint Paper Figures</h2>
	-->
    <p style="margin:50px">
		<a href="https://www.cell.com/cancer-cell/fulltext/S1535-6108(20)30659-0" target=_blank>GenomePaint paper</a>
		&nbsp;
		<a href="https://docs.google.com/document/d/1owXUQuqw5hBHFERm0Ria7anKtpyoPBaZY_MCiXXf5wE/edit?usp=sharing" target=_blank>User tutorial</a>
		&nbsp;
		<a href="https://docs.google.com/document/d/1iN6Eq86rV4v-tcDeki6boZAmmDB7T7oPRc3jXzEb3lg/edit?usp=sharing" target=_blank>Data release</a>
	</p>
    <div>
        <ul class="list-group">
            <li class="list-group-item"><a href="https://proteinpaint.stjude.org/gp/tall.tal1.prlr.html" target="_blank"><strong>Figure 2:</strong> Visualizing common or rare regulatory variants in T-ALL samples on Cohort View.</a>
            </li>
            <li class="list-group-item"><a href=" https://proteinpaint.stjude.org/gp/myc.sv.nb69.html" target="_blank"><strong>Figure 3:</strong> Sample View of interchromsomal rearrangement leading to <i>MYC</i> dysregulation by enhancer hijacking.</a>
            </li>
            <li class="list-group-item"><a href="https://proteinpaint.stjude.org/gp/crebbp.splicesite.html" target="_blank"><strong>Figure 4:</strong> Assessing aberrant splicing in <i>CREBBP</i> caused by somatic splice site variants.</a>
            </li>
            <li class="list-group-item"><a href="https://proteinpaint.stjude.org/gp/myc.enhancer.nalm6.html" target="_blank"><strong>Figure 5:</strong> <i>MYC</i> dysregulation by enhancer duplications in pediatric cancers.</a>
            </li>
            <li class="list-group-item"><a href="https://proteinpaint.stjude.org/gp/tcga.gbm.html" target="_blank"><strong>Figure 7:</strong> Visualizing intratumor heterogeneity of TCGA GBM at <i>EGFR</i> locus.</a>
            </li>
            <li class="list-group-item"><a href="https://proteinpaint.stjude.org/gp/tp53.html" target="_blank"><strong>Online example 1:</strong> <i>TP53</i> bi-allelic loss in adrenocortical tumors.</a>
            </li>
            <li class="list-group-item"><a href="https://proteinpaint.stjude.org/gp/ikzf1.html" target="_blank"><strong>Online example 2:</strong> <i>IKZF1</i> haploinsufficiency in B-ALL.</a>
            </li>
            <li class="list-group-item"><a href="https://proteinpaint.stjude.org/gp/tall.myb.KM.html " target="_blank"><strong>Online example 3:</strong> <i>MYB</i> alteration status in T-ALL and the association with patient outcome.</a>
            </li>
            <li class="list-group-item"><a href="https://proteinpaint.stjude.org/gp/aml.mdm2.KM.html" target="_blank"><strong>Online example 4:</strong> Association of <i>MDM2</i> expression in AML with patient outcome.</a>
            <li class="list-group-item"><a href="https://proteinpaint.stjude.org/gp/matrix.nbl.KM.html" target="_blank"><strong>Online example 5:</strong> Matrix View of mutual-exclusive or co-mutation patterns and association with patient outcome.</a>
            <li class="list-group-item"><a href="https://proteinpaint.stjude.org/gp/sampleview.splice.html" target="_blank"><strong>Online example 6:</strong> A <i>TP53</i> splice site mutation causing intron retention inspected via Sample View.</a>
            <li class="list-group-item"><a href="https://proteinpaint.stjude.org/gp/sampleview.kataegis.html" target="_blank"><strong>Online example 7:</strong> APOBEC signature is associated with kataegis as revealed by rainfall plot in Sample View.</a>
            <li class="list-group-item"><a href="https://proteinpaint.stjude.org/gp/tcga.dlbc.html" target="_blank"><strong>Online example 8:</strong> TCGA DLBC cohort mutation profile over <i>CDKN2A/B</i> locus.</a>
            <li class="list-group-item"><a href="https://proteinpaint.stjude.org/gp/tcga.skcm.html" target="_blank"><strong>Online example 9:</strong> TCGA SKCM cohort mutation profile over <i>TERT</i>.</a>   
            <li class="list-group-item"><a href="https://proteinpaint.stjude.org/gp/crebbp.deletion.html" target="_blank"><strong>Supplementary figure 2:</strong> Diverse alterations in B-ALL targeting <i>CREBBP</i> RING domain.</a>
            </li>
            <li class="list-group-item"><a href="https://proteinpaint.stjude.org/gp/myc.enhancer.newcases.hic.html" target="_blank"><strong>Supplementary figure 3:</strong> CNV and chromatin interactions over <i>MYC</i> and its enhancers.</a>
            </li>
            <li class="list-group-item"><a href="https://proteinpaint.stjude.org/gp/myc.enhancer.nalm6.phased.dux4.html" target="_blank"><strong>Supplementary figure 4:</strong> DUX4 but not NOTCH1 likely binds at N-ME in NALM6.</a>
            </li>
            <li class="list-group-item"><a href="https://proteinpaint.stjude.org/gp/tcga.gbm.clonality.html" target="_blank"><strong>Supplementary figure 5:</strong> In <i>EGFR</i>-amplified GBM, clonality of oncogenic coding mutations can vary with the presence or absence of the vIII isoform.</a>
            </li>
            <li class="list-group-item"><a href="https://proteinpaint.stjude.org/gp/tcga.gbm.itdsnv.html" target="_blank"><strong>Supplementary figure 6:</strong> Illustrating the <i>EGFR</i> exon 8 ITD event along with the reinterpretation of a sequence mutation.</a>
            </li>
        </ul>
    </div>
</body>
</html>
